Phase 2 Schizophrenia Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been officially diagnosed with schizophrenia according to standard diagnostic guidelines (DSM-5)
• Your mental health has been stable for at least 6 months before the study starts, and your main symptoms are "negative symptoms" (such as low motivation, reduced emotions, or social withdrawal) that have been present for at least 6 months, with scores on standard symptom rating scales meeting specific thresholds (confirm with trial site)
• You are in generally good physical health and your routine blood tests and lab results show no significant concerns
• You have been taking the same dose of antipsychotic medication for at least 6 months and are willing to keep that same dose unchanged for the 12-week study period
• You have enough education and communication ability to understand and complete the study assessments
• You are willing to take part and can sign a written consent form

Who may not be able to join:

• You have a diagnosis of intellectual disability or a problem with substance or alcohol use (according to DSM-5 guidelines)
• You have a history of epilepsy, a significant head injury, or other serious medical or brain/nervous system conditions (apart from schizophrenia) that could affect the study
• You have noticeable symptoms of depression, or your score on a standard depression rating scale is above a certain level (confirm with trial site)
• You have significant movement-related side effects sometimes linked to medication (such as stiffness or tremor), or your score on a standard movement rating scale is above a certain level (confirm with trial site)
• You are currently pregnant or breastfeeding
• You are unable or unwilling to follow the study procedures and requirements

Important: Always verify eligibility with the trial site directly before applying.